FirmaIQ
Org.nr 915 157 882 AS · OSLO · 21.200 Produksjon av farmasøytiske preparater Østensjøveien 27, 0661 OSLO Latest filing: Årsregnskap 2025 · approved 23.04.2026 · journal 2026 748965 Analysis generated: 09 Sep 2026 · Auto-onboard

VISTIN PHARMA ASA

VISTIN PHARMA ASA · 12 published annual accounts (2014–2025). Latest year revenue 452.3k NOK, net result 11.0m NOK, equity 139.6m NOK, cash 1.3m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2014–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Simple version

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 452.3k

Operating income / revenue in 2025.

Did they make money?
11.0m

Net result for 2025.

What’s left in the company
Equity 139.6m

Book equity at year-end.

Cash
1.3m

Bank deposits and cash (when disclosed).

At a glance · 2025

Key figures

Revenue / sales
452 291
NOK · [R2025]
Net result
10 989 000
NOK · [R2025]
Equity
139 593 000
NOK · [R2025]
Cash
1 271 000
NOK · [R2025]
Total assets
142 210 000
NOK · [R2025]
Paid-in equity
118 212 000
NOK · [R2025]

Trends

12-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.